For the Inventor, By the Inventor

Enter inventor name

Shanghai, China

Zhen Gong

USPTO Granted Patents = 13 (Patent Applications = 3)

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 9 (Patent Applications = 14)

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 53(Granted Patents)

Location History:

Jiangsu, CN (2021)
Shanghai, CN (2015 - 2024)

Company Filing History:

Glaxosmithkline Intellectual Property Development Limited

Medshine Discovery Inc.

Cspc Zhongqi Pharmaceutical Technology (shijiazhuang) Co., Ltd.

Chia Tai Tianqing Pharmaceutical Group Go., Ltd.

Guangdong Raynovent Biotech Co., Ltd.

Wuxi Life Fountain Biotech Co., Ltd

7. 1 out of 118

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd.

Cstone Pharmaceuticals

Cstone Pharmaceutical (suzhou) Co., Ltd.

Cstone Pharmaceuticals (shanghai) Co., Ltd.

12. 1 out of 14

Shanghai Hansoh Biomedical Co., Ltd.

13. 1 out of 24

Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

Loading Chart...

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12497366 - Nitrogen-containing heterocyclic derivative inhibitor, preparation method therefor and use thereof (2025-12-16),

2. 12312347 - Azaindole derivative and use thereof as FGFR and C-Met inhibitor (2025-05-27),

3. 11932652 - Pyrrolidinyl urea derivatives and application thereof in TrkA-related diseases (2024-03-19),

4. 11891398 - 2,3-dihydro-1H-pyrrolizine-7-formamide derivative and application thereof (2024-02-06),

5. 11680070 - Thieno[2,3-c]pyridazin-4(1H)-one derivative and application thereof (2023-06-20),

6. 11312726 - Thienodiazepine derivatives and application thereof (2022-04-26),

7. 11230544 - Substituted 1,3,4-thiadiazoles as GLS1 inhibitors (2022-01-25),

8. 11021486 - Coumarin-like cyclic compound as MEK inhibitor and use thereof (2021-06-01),

9. 11014943 - Azetidine derivative (2021-05-25),

10. 10526320 - Pyrrolidine derivatives as PPAR agonists (2020-01-07),

11. 10294236 - Compounds as rearranged during transfection (RET) inhibitors (2019-05-21),

12. 9879021 - Compounds as rearranged during transfection (RET) inhibitors (2018-01-30),

13. 8937071 - Compounds as rearranged during transfection (RET) inhibitors (2015-01-20),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…